These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
105 related items for PubMed ID: 1919182
1. [Changes in serum androgen levels in patients with polycystic ovary syndrome]. Yoshino K, Takahashi K, Nishigaki A, Eda Y, Kitao M. Nihon Sanka Fujinka Gakkai Zasshi; 1991 Sep; 43(9):1214-8. PubMed ID: 1919182 [Abstract] [Full Text] [Related]
4. Serum levels of 3alpha-androstanediol glucuronide in young women with polycystic ovary syndrome, idiopathic hirsutism and in normal subjects. Meczekalski B, Slopien R, Warenik-Szymankiewicz A. Eur J Obstet Gynecol Reprod Biol; 2007 May; 132(1):88-92. PubMed ID: 16979812 [Abstract] [Full Text] [Related]
5. Serum total L-carnitine levels in non-obese women with polycystic ovary syndrome. Fenkci SM, Fenkci V, Oztekin O, Rota S, Karagenc N. Hum Reprod; 2008 Jul; 23(7):1602-6. PubMed ID: 18378560 [Abstract] [Full Text] [Related]
7. Binding capacity of sex-hormone-binding globulin and free testosterone determination in evaluation of hirsute women. Ohsawa M, Narita O, Ichikawa Y, Masahashi T, Wu MC, Suganuma N, Asai M, Mizutani S, Tomoda Y, Matsui N. Nihon Sanka Fujinka Gakkai Zasshi; 1985 Mar; 37(3):416-20. PubMed ID: 4038991 [Abstract] [Full Text] [Related]
8. Serum testosterone, dihydrotestosterone and sex hormone binding globulin (SHBG) in girls with hirsutism and menstrual disturbances). Szamatowicz M, Kulikowski M. Endokrinologie; 1979 Feb; 73(1):20-6. PubMed ID: 572765 [Abstract] [Full Text] [Related]
10. [Exploration of the classification of polycystic ovarian syndrome]. Lin JF, Li X, Zhu MW. Zhonghua Fu Chan Ke Za Zhi; 2006 Oct; 41(10):684-8. PubMed ID: 17199924 [Abstract] [Full Text] [Related]
11. Effect of long-term orlistat treatment on serum levels of advanced glycation end-products in women with polycystic ovary syndrome. Diamanti-Kandarakis E, Katsikis I, Piperi C, Alexandraki K, Panidis D. Clin Endocrinol (Oxf); 2007 Jan; 66(1):103-9. PubMed ID: 17201808 [Abstract] [Full Text] [Related]
12. Obesity regulates bioavailable testosterone levels in women with or without polycystic ovary syndrome. Penttilä TL, Koskinen P, Penttilä TA, Anttila L, Irjala K. Fertil Steril; 1999 Mar; 71(3):457-61. PubMed ID: 10065782 [Abstract] [Full Text] [Related]
13. Impact of glycemic variations on the regulation of androgen metabolism in obese women with polycystic ovary syndrome. Ludwig AK, Goharian LG, Dietze T, Tauchert S, Rudolf S, Diedrich K, Schweiger U, Oltmanns KM. Fertil Steril; 2009 Jul; 92(1):271-6. PubMed ID: 18692843 [Abstract] [Full Text] [Related]
16. Obesity, weight loss, and the polycystic ovary syndrome: effect of treatment with diet and orlistat for 24 weeks on insulin resistance and androgen levels. Panidis D, Farmakiotis D, Rousso D, Kourtis A, Katsikis I, Krassas G. Fertil Steril; 2008 Apr; 89(4):899-906. PubMed ID: 17980364 [Abstract] [Full Text] [Related]